NHS rejects Roche’s Perjeta Breast cancer drug which claimed to boost survival by five years
A breast cancer drug earlier rejected by the NHS has been found in a recent study to actually boost survival chances by about five years in women. Perjeta was a breast cancer drug manufactured by Roche, and it ...